3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
13
Pain, Postoperative
10
Neoplasms
8
Agnosia
8
Multiple Myeloma
7
Cancer Pain
5
Breast Neoplasms
5
Lung Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Trigger Finger Disorder
2
Lymphoma
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglion Cysts
2
De Quervain Disease
2
Chronic Pain
2
Burkitt Lymphoma
2
Acute Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Strabismus
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency
1
Interventions
Dexamethasone
29
Aprepitant
24
Palonosetron
20
Ondansetron
20
Calcium Dobesilate
13
Olanzapine
12
Granisetron
11
Therapeutics
7
fosaprepitant
6
Doxorubicin
6
Cyclophosphamide
6
dexamethasone acetate
5
netupitant
4
Vincristine
4
dolasetron
3
Yoga
3
Tropisetron
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Metoclopramide
3
Lorazepam
3
Dronabinol
3
Acupressure
3
peppermint oil
2
netupitant, palosentron drug combination
2
ginger extract
2
dexamethasone 21-phosphate
2
Sugars
2
Rituximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Nausea
×
Acetaminophen
×
Clear all
NCT01474304
2016-09-29
IVAC
Swedish Medical Center
Phase 2
Unknown
80 enrolled